Use of medroxyprogesterone acetate and risk of meningiomas: a comparative safety study
MPAuse is linked to a substantially increased risk of meningiomas, underscoring the importance of assessing its long-term use. Further research is warranted to confirm these findings and guide clinical practice.
Authors
- Connor Frey (ORCID: https://orcid.org/0000-0002-4080-3030)
- Abbas Kezouh
- Mohit Sodhi (ORCID: https://orcid.org/0000-0001-6583-5277)
- Mahyar Etminan (ORCID: https://orcid.org/0000-0002-6421-3043)
- Mostafa Fatehi
Institutions
- University of British Columbia (CA)
Publication Details
- Journal
- Expert Opinion on Drug Safety
- Published
- 2025-06-30
- DOI
- https://doi.org/10.1080/14740338.2025.2526787
- Primary Topic
- Meningioma and schwannoma management
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- University of British Columbia